Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial

EJ Gault, RJ Perry, TJ Cole, S Casey, WF Paterson… - Bmj, 2011 - bmj.com
Objective To examine the effect of oxandrolone and the timing of pubertal induction on final
height in girls with Turner's syndrome receiving a standard dose of growth hormone. Design …

Hormones and Genes of Importance in Bone Physiology and Their Influence on Bone Mineralization and Growth in Turner SyndromeA Summary of the Joint …

AC Andrade, J Baron, SC Manolagas… - Hormone research in …, 2010 - karger.com
This mini review summarizes papers presented in a Joint Symposium between the Bone,
Growth Plate and Turner Syndrome Working Groups of the European Society for Paediatric …

Effect of oxandrolone and timing of pubertal induction on final height in Turner syndrome: final analysis of the UK randomised placebo-controlled trial

EJ Gault, TJ Cole, S Casey, PC Hindmarsh… - Archives of Disease in …, 2021 - adc.bmj.com
The UK Turner syndrome (TS) study examined the effect on final height of oxandrolone 0.05
mg/kg/day (maximum dose 2.5 mg) versus placebo from 9 years of age; and delaying …

Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study

RJ Perry, EJ Gault, WF Paterson, DB Dunger… - Hormone Research in …, 2014 - karger.com
Background: A UK study showed final height in Turner syndrome (TS) girls receiving growth
hormone is affected by age at pubertal induction and oxandrolone (Ox). Using data from that …

Short Stature Screening by Accurate Length Measurement in Infants with a Birth Weight< 9th Centile

C Montgomery Sardar, S Kinmond, J Siddique… - Hormone Research in …, 2015 - karger.com
Abstract Background/Aims: Intrauterine growth restriction is an indication for growth
hormone treatment. Birth length (BL) is needed to evaluate the influence of birth size on …

[HTML][HTML] Measured parental height in Turner syndrome—a valuable but underused diagnostic tool

Y Ouarezki, FM Cizmecioglu, C Mansour… - European Journal of …, 2018 - Springer
Early diagnosis of Turner syndrome (TS) is necessary to facilitate appropriate management,
including growth promotion. Not all girls with TS have overt short stature, and comparison …

Prevalence, risk factors and management strategies for otological problems in girls with Turner syndrome

D Lim, S Hassani, K Lupton, EJ Gault… - Acta …, 2020 - Wiley Online Library
Aim To determine the prevalence and risk factors of ear disease in Turner syndrome (TS),
propose an algorithm for future surveillance and recommend preventative strategies …

Final height in Turner syndrome after Oxandrolone and delayed pubertal induction: results of a UK randomised, double-blind, placebo-controlled trial

EJ Gault, R Perry, S Casey, T Cole… - Endocrine …, 2009 - endocrine-abstracts.org
Methods: Girls with TS aged 7–13y receiving GH were randomised to Ox (0.05 mg/kg per
day, max. dose 2.5 mg/day) or placebo from 9y (or from enrolment if> 9y). Girls requiring …

[PDF][PDF] DR. DAVID BOON NGAN LIM (Orcid ID: 0000-0002-3174-5051)

D Lim, S Hassani, K Lupton, EJ Gault, D Wynne… - minerva-access.unimelb.edu.au
Aim: To determine the prevalence and risk factors of ear disease in Turner Syndrome (TS),
propose an algorithm for future surveillance, and recommend preventative strategies …

[CITATION][C] Oestrogen replacement in Turner syndrome: current prescribing practice in the UK

EJ Gault, MDC Donaldson - Clinical endocrinology, 2009 - Wiley Online Library
The majority of girls with Turner syndrome (TS) will have primary ovarian failure requiring
oestrogen replacement. 1 In adolescence the main goal of oestrogen is to induce puberty; …